Skip to main content
Clinical Trials/NCT03383016
NCT03383016
Active, not recruiting
Not Applicable

Interaction Between Environment, Diet, Physical Activities, and Sexual Habits, in the Risk of Prostate Cancer. Validation of Biomarkers to Personalize Preventive Interventions (BIOCaPPE)

CHU de Quebec-Universite Laval4 sites in 1 country2,053 target enrollmentJune 20, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epidemiology
Sponsor
CHU de Quebec-Universite Laval
Enrollment
2053
Locations
4
Primary Endpoint
Biomarkers and modifiable exposure environment
Status
Active, not recruiting
Last Updated
4 months ago

Overview

Brief Summary

The risk of prostate cancer is associated with lifestyle habits, such as diet and physical activity. Indeed, results of numerous studies suggest links between obesity, diabetes, inflammation and androgen and estrogen metabolism in the pathogenesis of prostate cancer.

The goal of BIOCaPPE study (Biomarkers and Prostate Cancer/ Prevention and Environment) is to identify biomarkers of prostate cancer risk that are potentially modifiable by environmental exposures (e.g. diet and physical activity).

A selection of few of the most promising biological markers will be evaluated in a cohort of more than 2000 men at high-risk of prostate cancer.

Such biomarkers would provide a practical approach to identify men at high risk of prostate cancer who could benefit from interventions aiming at reducing their risk. The biomarkers would also be useful to monitor the efficacy of the interventions on patient's lifestyle.

Detailed Description

The main objective of the proposed research project is to assess the association between five candidate biological markers potentially modifiable by environmental exposures (diet and physical activity) and the two-year risk of prostate cancer in a newly recruited cohort of men at high-risk of prostate cancer showing no evidence of cancer. Four hospitals in the province of Quebec (Canada) participate to the recruitment of 2,055 men at high-risk for prostate cancer, i.e. men who had a first negative prostate biopsy or whose Prostatic Specific Antigen (PSA) level is between 2.5 and 10 ng/mL without previous prostate biopsy. The candidate biomarkers that will be tested are: 1. The ratio of ω-3/ ω-6 fatty acid content of red blood cell membranes, 2. Oxidized low density lipoprotein cholesterol 3. Adiponectin 4. Insulin growth factor-1 5. The ratio of dihydrotestosterone glucuronide derivatives over estradiol A biobank, composed of biological material (whole blood, plasma, serum, lymphocyte layer and excess tissue collected from prostate biopsy or prostate surgery) and clinical data is being created. Questionnaires are used to compile information on socio-demographic aspects, family and personal medical history, quality of life, lifestyle like food and sexual habits.

Registry
clinicaltrials.gov
Start Date
June 20, 2013
End Date
September 1, 2030
Last Updated
4 months ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
CHU de Quebec-Universite Laval
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Group 1: A first negative prostate biopsy within 6 months
  • Group 2: serum-PSA level between 2.5-10 ng/mL and no prior prostate biopsy

Exclusion Criteria

  • Prostate cancer
  • Positive result for transurethral prostatic resection

Outcomes

Primary Outcomes

Biomarkers and modifiable exposure environment

Time Frame: An average of 2 years

Assess the association between five candidate biological markers potentially modifiable by environmental exposures, mainly diet and physical activity, with the two-year risk of prostate cancer in men at risk for prostate cancer as previously defined.

Secondary Outcomes

  • Study biobank(Through study completion, every year up to 2 years)

Study Sites (4)

Loading locations...

Similar Trials